Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

736 Articles

Chris Lange | Sep 25, 2015 at 8:05 AM EDT

Short Sellers Increase Bets in Major Biotech

The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks…

Jon C. Ogg | Sep 24, 2015 at 10:25 AM EDT

8 Great Value Stocks With Solid Dividends Under 10 Times Earnings

After the sell-off, there are now many more solid and well-established dividend-paying companies valued at less than 10 times earnings.

Jon C. Ogg | Sep 18, 2015 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: Aetna, Eli Lilly, Gilead, Royal Gold, Sirius XM and Many More

Friday’s top analyst upgrades, downgrades and initiations include Aetna, Eli Lilly, Gilead Sciences, Royal Gold and Sirius XM.

Chris Lange | Sep 11, 2015 at 8:05 AM EDT

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased…

Jon C. Ogg | Sep 10, 2015 at 10:50 AM EDT

Biogen Follows Gilead With Large Debt Offering

ThinkstockAre biotech companies going to become the next big companies saddled with debt? Most likely not, but two debt offerings…

Jon C. Ogg | Sep 9, 2015 at 11:10 AM EDT

Why Gilead Faces Unenthusiastic Ratings Into Massive Debt Offering

Gilead Sciences is going to raise cash via a huge debt offering. Will this cash be used to fund a…

Chris Lange | Aug 26, 2015 at 8:55 AM EDT

Short Sellers Become More Focused in Major Biotechs

The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of…

Jon C. Ogg | Aug 24, 2015 at 11:35 AM EDT

Projected Prices Where Investors Are Interested: Apple, JPMorgan, Ford, GE, Gilead

24/7 Wall St. has wanted to check on the major stocks in the market with an eagle-eye view of where…

Chris Lange | Aug 12, 2015 at 8:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech…

Chris Lange | Jul 29, 2015 at 1:27 PM EDT

Should Gilead Really Be Rated Underperform?

ThinkstockMost analysts seem to be behind the growth that Gilead Sciences Inc. (NASDAQ: GILD) has seen, namely in its Hepatitis…

Jon C. Ogg | Jul 29, 2015 at 8:54 AM EDT

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

Jon OggStocks were indicated higher on Wednesday ahead of the pending FOMC decision on interest rates. Tuesday’s rally was yet…

Chris Lange | Jul 28, 2015 at 4:54 PM EDT

Gilead Tops Estimates in 2Q

courtesy of Gilead SciencesGilead Sciences Inc. (NASDAQ: GILD) reported second-quarter financial results Tuesday after the markets closed. The biotech giant…

Chris Lange | Jul 27, 2015 at 7:57 AM EDT

Short Sellers Back Off Major Biotechs

ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of…

Jon C. Ogg | Jul 26, 2015 at 10:21 AM EDT

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings…

Jon C. Ogg | Jul 21, 2015 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Alarm.com, Pandora, PayPal, SanDisk, SunEdison, Tesla, AMD and More

Tuesday's top analyst upgrades, downgrades and initiations include Alarm.com, Pandora Media, PayPal, SanDisk, SunEdison, Tesla Motors and Advanced Micro Devices.

1 … 30 31 32 33 34 … 50

Gilead Sciences : GILD

All Gilead Sciences Articles

Short Sellers Increase Bets in Major Biotech

8 Great Value Stocks With Solid Dividends Under 10 Times Earnings

Top Analyst Upgrades and Downgrades: Aetna, Eli Lilly, Gilead, Royal Gold, Sirius XM and Many More

Short Sellers Increase Bets in Major Biotechs

Biogen Follows Gilead With Large Debt Offering

Why Gilead Faces Unenthusiastic Ratings Into Massive Debt Offering

Short Sellers Become More Focused in Major Biotechs

Projected Prices Where Investors Are Interested: Apple, JPMorgan, Ford, GE, Gilead

Short Sellers Run for Cover From Major Biotechs

Should Gilead Really Be Rated Underperform?

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

Gilead Tops Estimates in 2Q

Short Sellers Back Off Major Biotechs

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

Top Analyst Upgrades and Downgrades: Alarm.com, Pandora, PayPal, SanDisk, SunEdison, Tesla, AMD and More

David Tepper Just Made a $107 Million Bet on Top AI Stock. George Soros Is Holding Puts Against It.

Nuclear Stocks Plunge Tuesday: Oklo Down 5%, Constellation Energy Down 4%, NuScale Down 5%

The Own-Occupation Disability Policy a 41-Year-Old Surgeon Just Renewed at Half Her Old Premium Despite Earning Twice as Much

The Own-Occupation Disability Policy a 41-Year-Old Surgeon Just Renewed at Half Her Old Premium Despite Earning Twice as Much

The USDA Paid Him Rent on 200 Retired Acres. Claiming Social Security Changed the Tax on the Same Check.

David Tepper Just Made a $107 Million Bet on Top AI Stock. George Soros Is Holding Puts Against It.

Nuclear Stocks Plunge Tuesday: Oklo Down 5%, Constellation Energy Down 4%, NuScale Down 5%

Gilead Sciences : GILD

All Gilead Sciences Articles

Short Sellers Increase Bets in Major Biotech

8 Great Value Stocks With Solid Dividends Under 10 Times Earnings

Top Analyst Upgrades and Downgrades: Aetna, Eli Lilly, Gilead, Royal Gold, Sirius XM and Many More

Short Sellers Increase Bets in Major Biotechs

Biogen Follows Gilead With Large Debt Offering

Why Gilead Faces Unenthusiastic Ratings Into Massive Debt Offering

Short Sellers Become More Focused in Major Biotechs

Projected Prices Where Investors Are Interested: Apple, JPMorgan, Ford, GE, Gilead

Short Sellers Run for Cover From Major Biotechs

Should Gilead Really Be Rated Underperform?

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

Gilead Tops Estimates in 2Q

Short Sellers Back Off Major Biotechs

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

Top Analyst Upgrades and Downgrades: Alarm.com, Pandora, PayPal, SanDisk, SunEdison, Tesla, AMD and More

David Tepper Just Made a $107 Million Bet on Top AI Stock. George Soros Is Holding Puts Against It.

Nuclear Stocks Plunge Tuesday: Oklo Down 5%, Constellation Energy Down 4%, NuScale Down 5%

The Own-Occupation Disability Policy a 41-Year-Old Surgeon Just Renewed at Half Her Old Premium Despite Earning Twice as Much

Featured Reads

The Own-Occupation Disability Policy a 41-Year-Old Surgeon Just Renewed at Half Her Old Premium Despite Earning Twice as Much

The USDA Paid Him Rent on 200 Retired Acres. Claiming Social Security Changed the Tax on the Same Check.